|
1
|
Halpin DMG, Criner GJ, Papi A, Singh D,
Anzueto A, Martinez FJ, Agusti AA and Vogelmeier CF: Global
initiative for the diagnosis, management, and prevention of chronic
obstructive lung disease. The 2020 GOLD science committee report on
COVID-19 and chronic obstructive pulmonary disease. Am J Respir
Crit Care Med. 203:24–36. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Labaki WW and Rosenberg SR: Chronic
obstructive pulmonary disease. Ann Intern Med. 173:ITC17–ITC32.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kim V and Criner GJ: Chronic bronchitis
and chronic obstructive pulmonary disease. Am J Respir Crit Care
Med. 187:228–237. 2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ruvuna L and Sood A: Epidemiology of
chronic obstructive pulmonary disease. Clin Chest Med. 41:315–327.
2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Iheanacho I, Zhang S, King D, Rizzo M and
Ismaila AS: Economic burden of chronic obstructive pulmonary
disease (COPD): A systematic literature review. Int J Chron
Obstruct Pulmon Dis. 15:439–460. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Negewo NA, Gibson PG and McDonald VM: COPD
and its comorbidities: Impact, measurement and mechanisms.
Respirology. 20:1160–1171. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Decramer M, Janssens W and Miravitlles M:
Chronic obstructive pulmonary disease. Lancet. 379:1341–1351.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lauder L, Mahfoud F, Azizi M, Bhatt DL,
Ewen S, Kario K, Parati G, Rossignol P, Schlaich MP, Teo KK, et al:
Hypertension management in patients with cardiovascular
comorbidities. Eur Heart J. 44:2066–2077. 2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Li Z, Zhao H and Wang J: Metabolism and
chronic inflammation: The links between chronic heart failure and
comorbidities. Front Cardiovasc Med. 8(650278)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Keshishian A, Xie L, Dembek C and Yuce H:
Reduction in hospital readmission rates among medicare
beneficiaries with chronic obstructive pulmonary disease: A
Real-world Outcomes Study of Nebulized Bronchodilators. Clin Ther.
41:2283–2296. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhou T, Liu P, Dhruva SS, Shah ND,
Ramachandran R, Berg KM and Ross JS: Assessment of hypothetical
out-of-pocket costs of guideline-recommended medications for the
treatment of older adults with multiple chronic conditions, 2009
and 2019. JAMA Intern Med. 182:185–195. 2022.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chugh SS, Havmoeller R, Narayanan K, Singh
D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr,
Zheng ZJ, et al: Worldwide epidemiology of atrial fibrillation: A
global burden of disease 2010 study. Circulation. 129:837–847.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Romiti GF, Corica B, Pipitone E, Vitolo M,
Raparelli V, Basili S, Boriani G, Harari S, Lip GYH and Proietti M:
AF-COMET International Collaborative Group. Prevalence, management
and impact of chronic obstructive pulmonary disease in atrial
fibrillation: A systematic review and meta-analysis of 4,200,000
patients. Eur Heart J. 42:3541–3554. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Goudis CA, Konstantinidis AK, Ntalas IV
and Korantzopoulos P: Electrocardiographic abnormalities and
cardiac arrhythmias in chronic obstructive pulmonary disease. Int J
Cardiol. 199:264–273. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Naser N, Dilic M, Durak A, Kulic M, Pepic
E, Smajic E and Kusljugic Z: The impact of risk factors and
comorbidities on the incidence of atrial fibrillation. Mater
Sociomed. 29:231–236. 2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang Q, Xiong H, Shuai T, Zhang M, Zhang
C, Wang Y, Zhu L, Lu J and Liu J: Risk factors for new-onset atrial
fibrillation in patients with chronic obstructive pulmonary
disease: A systematic review and meta-analysis. PeerJ.
8(e10376)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wood-Baker R, Cochrane B and Naughton MT:
Cardiovascular mortality and morbidity in chronic obstructive
pulmonary disease: The impact of bronchodilator treatment. Intern
Med J. 40:94–101. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tousoulis D: Biomarkers in atrial
fibrillation; From pathophysiology to diagnosis and treatment. Curr
Med Chem. 26:762–764. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Humbert M, Kovacs G, Hoeper MM,
Badagliacca R, Berger RMF, Brida M, Carlsen J, Coats AJS,
Escribano-Subias P, Ferrari P, et al: 2022 ESC/ERS Guidelines for
the diagnosis and treatment of pulmonary hypertension. Eur Respir
J. 61(2200879)2023.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ranstam J and Cook JA: Kaplan-Meier curve.
Br J Surg. 104(442)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Abraham CR and Li A: Aging-suppressor
Klotho: Prospects in diagnostics and therapeutics. Ageing Res Rev.
82(101766)2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Guo Y, Tian Y, Wang H, Si Q, Wang Y and
Lip GYH: Prevalence, incidence, and lifetime risk of atrial
fibrillation in China: New insights into the global burden of
atrial fibrillation. Chest. 147:109–119. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Koshiyama M, Tamaki K and Ohsawa M:
Age-specific incidence rates of atrial fibrillation and risk
factors for the future development of atrial fibrillation in the
Japanese general population. J Cardiol. 77:88–92. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
McDonough JE, Yuan R, Suzuki M, Seyednejad
N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson
HO, et al: Small-airway obstruction and emphysema in chronic
obstructive pulmonary disease. N Engl J Med. 365:1567–1575.
2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Guo J, Chen Y, Zhang W, Tong S and Dong J:
Moderate and severe exacerbations have a significant impact on
health-related quality of life, utility, and lung function in
patients with chronic obstructive pulmonary disease: A
meta-analysis. Int J Surg. 78:28–35. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Soeki T, Matsuura T, Tobiume T, Bando S,
Matsumoto K, Nagano H, Uematsu E, Kusunose K, Ise T, Yamaguchi K,
et al: Clinical, electrocardiographic, and echocardiographic
parameter combination predicts the onset of atrial fibrillation.
Circ J. 82:2253–2258. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Debonnaire P, Joyce E, Hiemstra Y, Mertens
BJ, Atsma DE, Schalij MJ, Bax JJ, Delgado V and Marsan NA: Left
atrial size and function in hypertrophic cardiomyopathy patients
and risk of new-onset atrial fibrillation. Circ Arrhythm
Electrophysiol. 10(e004052)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vaziri SM, Larson MG, Benjamin EJ and Levy
D: Echocardiographic predictors of nonrheumatic atrial
fibrillation. The Framingham Heart Study. Circulation. 89:724–730.
1994.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Alfadhel M, Nestelberger T, Samuel R,
McAlister C and Saw J: Left atrial appendage closure-Current status
and future directions. Prog Cardiovasc Dis. 69:101–109.
2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mo BF, Lian XM and Li YG: Current evidence
on the safety and efficacy of combined atrial fibrillation ablation
and left atrial appendage closure. Curr Opin Cardiol. 37:74–79.
2022.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang H, Tang Z, Han Z, Zeng L and Wang C:
Role of real time-three dimensional transesophageal
echocardiography in left atrial appendage closure with LACBES(®)
devices. Exp Ther Med. 17:1456–1462. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Zhang Q, Wang JF, Dong QQ, Yan Q, Luo XH,
Wu XY, Liu J and Sun YP: Evaluation of left atrial volume and
function using single-beat real-time three-dimensional
echocardiography in atrial fibrillation patients. BMC Med Imaging.
17(44)2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sagris M, Vardas EP, Theofilis P,
Antonopoulos AS, Oikonomou E and Tousoulis D: Atrial fibrillation:
Pathogenesis, predisposing factors, and genetics. Int J Mol Sci.
23(6)2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hu YF, Chen YJ, Lin YJ and Chen SA:
Inflammation and the pathogenesis of atrial fibrillation. Nat Rev
Cardiol. 12:230–243. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Khalid K, Padda J, Komissarov A, Colaco
LB, Padda S, Khan AS, Campos VM and Jean-Charles G: The coexistence
of chronic obstructive pulmonary disease and heart failure. Cureus.
13(e17387)2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Canepa M, Franssen FME, Olschewski H,
Lainscak M, Böhm M, Tavazzi L and Rosenkranz S: Diagnostic and
therapeutic gaps in patients with heart failure and chronic
obstructive pulmonary disease. JACC Heart Fail. 7:823–833.
2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Grymonprez M, Vakaet V, Kavousi M,
Stricker BH, Ikram MA, Heeringa J, Franco OH, Brusselle GG and
Lahousse L: Chronic obstructive pulmonary disease and the
development of atrial fibrillation. Int J Cardiol. 276:118–124.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jesel L, Abbas M, Toti F, Cohen A, Arentz
T and Morel O: Microparticles in atrial fibrillation: A link
between cell activation or apoptosis, tissue remodelling and
thrombogenicity. Int J Cardiol. 168:660–669. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H,
Jiang J, Xu Y and Lu W: The role of oxidative stress in
hyperuricemia and xanthine oxidoreductase (XOR) inhibitors. Oxid
Med Cell Longev. 2021(1470380)2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Durmus Kocak N, Sasak G, Aka Akturk U,
Akgun M, Boga S, Sengul A, Gungor S and Arinc S: Serum uric acid
levels and uric acid/creatinine ratios in stable chronic
obstructive pulmonary disease (COPD) patients: Are these parameters
efficient predictors of patients at risk for exacerbation and/or
severity of disease? Med Sci Monit. 22:4169–4176. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Park JH, Jo YI and Lee JH: Renal effects
of uric acid: Hyperuricemia and hypouricemia. Korean J Intern Med.
35:1291–1304. 2020.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Hu L, Hu G, Xu BP, Zhu L, Zhou W, Wang T,
Bao H and Cheng X: U-Shaped association of serum uric acid with
all-cause and cause-specific mortality in US adults: A cohort
study. J Clin Endocrinol Metab. 105(dgz068)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Uk Kang T, Park KY, Kim HJ, Ahn HS, Yim SY
and Jun JB: Association of hyperuricemia and pulmonary
hypertension: A systematic review and meta-analysis. Mod Rheumatol.
29:1031–1041. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wu ZD, Yang XK, He YS, Ni J, Wang J, Yin
KJ, Huang JX, Chen Y, Feng YT, Wang P and Pan HF: Environmental
factors and risk of gout. Environ Res. 212(Pt
C)(113377)2022.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Li S, Cheng J, Cui L, Gurol ME, Bhatt DL,
Fonarow GC, Benjamin EJ, Xing A, Xia Y, Wu S and Gao X: Cohort
study of repeated measurements of serum urate and risk of incident
atrial fibrillation. J Am Heart Assoc. 8(e012020)2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Crawley WT, Jungels CG, Stenmark KR and
Fini MA: U-shaped association of uric acid to overall-cause
mortality and its impact on clinical management of hyperuricemia.
Redox Biol. 51(102271)2022.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Yang Y, Tian J, Zeng C, Wei J, Li LJ, Xie
X, Yang T, Li H and Lei GH: Relationship between hyperuricemia and
risk of coronary heart disease in a middle-aged and elderly Chinese
population. J Int Med Res. 45:254–260. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Perez-Ruiz F and Becker MA: Inflammation:
A possible mechanism for a causative role of hyperuricemia/gout in
cardiovascular disease. Curr Med Res Opin. 31 (Suppl 2):S9–S14.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Li N, Zhang S, Li W, Wang L, Liu H, Li W,
Zhang T, Liu G, Du Y and Leng J: Prevalence of hyperuricemia and
its related risk factors among preschool children from China. Sci
Rep. 7(9448)2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chao TF, Hung CL, Chen SJ, Wang KL, Chen
TJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC and Chen SA: The
association between hyperuricemia, left atrial size and new-onset
atrial fibrillation. Int J Cardiol. 168:4027–4032. 2013.PubMed/NCBI View Article : Google Scholar
|
